Back

Panel discussion and close.

22 May 2022 (15:25 - 15:40)
Organised by:
Congress Presentation Part of: A new era for HFpEF – Exploring the role of empagliflozin in practice Chronic Heart Failure Open Access Heart Failure 2022

About the speaker

Photo
Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

3 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor A. Stewart Coats (Sydney, AU)
Slides Video
Presentation thumbnail
What is the evidence for empagliflozin in HF?
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
Using empagliflozin for HFpEF treatment - what does this look like in practice?
Doctor S. Zieroth (Winnipeg, CA)
Slides Video

Access the full session

Session thumbnail
A new era for HFpEF – Exploring the role of empagliflozin in practice
Video

The Event

Event poster

Heart Failure 2022

22 May 2022 15:25 CET
You may be interested in
thumbnail
Congress Session
SGLT2 inhibitors across the spectrum of heart failure
21 May 2022
thumbnail
Congress Presentation
What is the evidence for empagliflozin in HFpEF?
27 August 2022
thumbnail
Congress Presentation
The evolution of heart failure care: where are we in 2026?
10 May 2026
thumbnail
Congress Session
Scientific wrap-up
21 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources